Skip to main content

Table 2 The relationship between MT1L expression and clinical characteristics in BLCA was analyzed by logistic regression with 408 samples obtained from TCGA

From: Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA

Clinical characteristics

Number

OR

p-value

Age

408

1.02 (1.00–1.04)

0.039

Gender

408

0.76 (0.48–1.18)

0.216

Weight

408

1.01 (1.00–1.02)

0.01

Race

Asian vs others

67

3.01 (1.06–9.21)

0.043

Asian vs White

369

5.56 (2.63–13.20)

<0.001

Others vs White

348

0.80 (0.33–1.87)

0.605

M (M0 vs M1)

207

2.95 (0.83–13.80)

0.118

N (N0 vs >N0)

366

0.61 (0.40–0.94)

0.026

Stage

I–II vs III

272

2.53 (1.56–4.14)

0

I–II vs IV

266

2.50 (1.54–4.12)

0

III vs IV

274

1.06 (0.66–1.70)

0.81

T

<T2 vs T3

317

2.26 (1.43–3.60)

0

<T2 vs T4

181

3.03 (1.59–5.98)

0.001

T3 vs T4

252

1.11 (0.62–2.01)

0.728

Grade (high vs low)

405

0.153 (0.04–0.46)

0.003